JC

John Curnutte

Board of Directors - Orchard Therapeutics; Board of Directors - Pliant Therapeutics; Consultant at Portola Therapeutics

San Francisco Bay Area

Investor
VC

Invests in

Stages:

Seed

  • Min Investment:

    $10,000,000.00

  • Max Investment:

    $100,000,000.00

  • Target Investment:

    $25,000,000.00

Skills

Translational Medicine
Inflammation
Biotechnology
R&D
Cell Biology
Biopharmaceuticals
Assay Development
Clinical Development
Drug Development
Biochemistry
Clinical Trials

Education

Work Experience

Cayuga Biotech

2024

  • Board Member

    2024

Samsara BioCapital

2020

  • Senior Advisor

    2020

Autobahn Labs, Inc.

2020

  • SAB Member

    2020

Pliant Therapeutics

2017

  • Board of Directors Member

    2017

Orchard Therapeutics

2019 - 2024

  • Board Member

    2019 - 2024

Portola Pharmaceuticals

2011 - 2020

  • Consultant

    2019 - 2020

  • Executive Vice President of Research & Development

    2011 - 2019

3-V Biosciences

2008 - 2010

  • CEO

    2008 - 2010

Schering-Plough Biopharma (formerly DNAX Research Institute)

2000 - 2008

  • President

    2000 - 2008

Genentech

1993 - 2000

  • Senior Director, Department of Immunology

    1993 - 2000

The Scripps Research Institite

1986 - 1993

  • Associate Professor (Tenured)

    1986 - 1993